variable name,title,element type,version,definition,short description,datatype,maximum character quantity,input restriction,minimum value,maximum value,permissible values,permissible value descriptions,permissible value output codes,unit of measure,guidelines/instructions,notes,preferred question text,keywords,references,population.all,domain.general (for all diseases),domain.traumatic brain injury,domain.Parkinson's disease,domain.Friedreich's ataxia,domain.stroke,domain.amyotrophic lateral sclerosis,domain.Huntington's disease,domain.multiple sclerosis,domain.neuromuscular diseases,domain.myasthenia gravis,domain.spinal muscular atrophy,domain.Duchenne muscular dystrophy/Becker muscular dystrophy,domain.congenital muscular dystrophy,domain.spinal cord injury,domain.headache,domain.epilepsy,classification.general (for all diseases),classification.acute hospitalized,classification.concussion/mild TBI,classification.epidemiology,classification.moderate/severe TBI: rehabilitation,classification.Parkinson's disease,classification.Friedreich's ataxia,classification.stroke,classification.amyotrophic lateral sclerosis,classification.Huntington's disease,classification.multiple sclerosis,classification.neuromuscular diseases,classification.myasthenia gravis,classification.spinal muscular atrophy,classification.Duchenne muscular dystrophy/Becker muscular dystrophy,classification.congenital muscular dystrophy,classification.spinal cord injury,classification.headache,classification.epilepsy,historical notes,Label(s),see also,submitting organization name,submitting contact name,submitting contact information,effective date,until date,steward organization name,steward contact name,steward contact information,creation date,last change date,administrative status
Abd_AIS,Abdominal AIS,UDE,1,AIS severity of injury for this body region,AIS severity of injury for this body region,NUMERIC,,1,,,"{5,6,2,1,4,3}","{5,6,2,1,4,3}","{NULL,NULL,NULL,NULL,NULL,NULL}",,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Acrnym,Acronym,CDE,1,"An acronym or abbreviation used to identify the clinical study, if any","An acronym or abbreviation used to identifythe clinical study, if any",ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AdmTemp,AdmTemp,UDE,1,Measurementof the participant's/subjects body temperature,First recorded temperature in the hospital within 30 minutes or less of hospital arrival (expressed in degrees Celsius),NUMERIC,150,0,0,150,{NULL},{NULL},{NULL},,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AgeYears,Age in years,CDE,1,"Value for participant's subject age, calculated as elapsed time since the birth of the participant/subject in years. The subjects age is typically recorded to the nearest full year completed, e.g. 11 years and 6 months should be recorded as 11 years",Value for participant's subject age recorded in years.,NUMERIC,150,0,0,150,{NULL},{NULL},{NULL},,,,Subject's age (recorded in years):,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AIS_Abd,Abdominal AIS,UDE,1,AIS severity of injury for this body region,AIS severity of injury for this body region,NUMERIC,,1,,,"{5,0,6,2,1,4,3}","{5,0,6,2,1,4,3}","{NULL,NULL,NULL,NULL,NULL,NULL,NULL}",,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AIS_Face,Face AIS,UDE,1,AIS severity of injury for this body region,AIS severity of injury for this body region,NUMERIC,,1,,,"{Extremity,Abdomen,External,Face,Chest,Head/Neck}","{5=Extremity,4=Abdomen,6=External,2=Face,3=Chest,1=Head/Neck}","{5,4,6,2,3,1}",,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AIS_Head,Head AIS,UDE,1,AIS severity of injury for this body region,AIS severity of injury for this body region,NUMERIC,,1,,,"{""AIS Military"",""AIS Revision 2005 Update 2008"",""AIS Revision 1990 Update 1998"",""AIS revison 1990"",""AIS Revision 2005"",""AIS Revision 2015""}","{""AIS Military"",""AIS Revision 2005 Update 2008"",""AIS Revision 1990 Update 1998"",""AIS Revision 1990"",""AIS Revision 2005"",""AIS Revision 2015""}","{1,3,5,6,4,2}",,,,Version of Abbreviated injury scale (AIS) dictionary,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AIS_LE,Lower Extremity AIS,UDE,1,AIS severity of injury for this body region,AIS severity of injury for this body region,NUMERIC,,1,,,"{5,6,2,1,4,3}","{5,6,2,1,4,3}","{NULL,NULL,NULL,NULL,NULL,NULL}",,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AIS_Neck,Neck AIS,UDE,1,AIS severity of injury for this body region,AIS severity of injury for this body region,NUMERIC,,1,,,"{5,0,6,2,1,4,3}","{5,0,6,2,1,4,3}","{NULL,NULL,NULL,NULL,NULL,NULL,NULL}",,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AIS_Spine,Spine AIS,UDE,1,AIS severity of injury for this body region,AIS severity of injury for this body region,NUMERIC,,1,,,"{5,0,6,2,1,4,3}","{5,0,6,2,1,4,3}","{NULL,NULL,NULL,NULL,NULL,NULL,NULL}",,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AIS_Thorax,Thorax AIS,UDE,1,AIS severity of injury for this body region,AIS severity of injury for this body region,NUMERIC,,1,,,{NULL},{NULL},{NULL},,,,AISCode pre-dot related text for code postions 2-6,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AIS_UE,Upper Extremity AIS,UDE,1,AIS severity of injury for this body region,AIS severity of injury for this body region,NUMERIC,,1,,,"{1,4,3,6,9,2,5}","{1=Minor,4=Severe,3=Serious,""6=Maximal (currently untreatable)"",""9=Unknown severity"",2=Moderate,5=Critical}","{1,4,3,6,9,2,5}",,,,AIS Injury Severity,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AISBodyRegion,Abbreviated injury scale (AIS) - Body region,CDE,1,The six body regions assessed with the 6 point intermediate ordinal severuty scale,The six body regions assessed with the 6 point intermediate ordinal severuty scale,ALPHANUMERIC,,1,,,{NULL},{NULL},{NULL},,"Choose one. For each AISInjurySeverityScore value, select the corresponding ISS  body region ",,AISCode pre-dot related text for code postions 2-6,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AISDictionaryVersionTyp,Abbreviated injury scale (AIS) - Dictionary version type,CDE,1,A type/version of the Abbreviated Injury Scale (AIS) dictionary used to assess the injury,A type/version of the Abbreviated Injury Scale (AIS) dictionary used to assess the injury,ALPHANUMERIC,,1,,,"{1,4,3,6,9,2,5}","{1=Minor,4=Severe,3=Serious,""6=Maximal (currently untreatable)"",""9=Unknown severity"",2=Moderate,5=Critical}","{1,4,3,6,9,2,5}",,Choose one. Use AIS user manual to find out the version. Recommend using the most recent version. AIS dictionaries developed earlier than 1990 are not recommended for use in this data collection,,AIS Injury Severity,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AISFace,Face AIS,UDE,1,AIS severity of injury for this body region,AIS severity of injury for this body region,NUMERIC,,1,,,"{5,0,6,2,1,4,3}","{5,0,6,2,1,4,3}","{NULL,NULL,NULL,NULL,NULL,NULL,NULL}",,"For each combination of values recorded in AISBodyRegionChapterCat-AISInjurySeverityScore,enter the injury description from the medical documentation. This description is used to code the injury in AIS Code and desribes the precise injury. The injury descriptor in AIS code (refer to AISCode CDE) comprises the six digits to the left of the dot; this pre-dot code contains values indicating AIS body region injured captured in AISBodyRegionChapterCat and the rest of information, such as, type of structure injured, specific anatomic structure injured, and level of injury, which should be entered in this DE. The injury is described in the pre-dot vocabulary terms for positions 2-6. Using controlled vocabulary from the corresponding version of AIS dictionary is highly recommended. Refer to AISCode for the corresponding AIS code. Consult the corresponding version of AIS dictionary for legal values",,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AISInjDscrptionTxt,Abbreviated injury scale (AIS) - injury clinical description text,CDE,1,"A clinical description of the subject injury(ies) from the medical documentation, as part of Abbreviated Injury Scale (AIS). The injury should preferably be described in the Abbreviated injury Scale code controlled vocabulary terms.","A clinical description of the subject injury(ies) from the medical documentation, as part of Abbreviated Injury Scale (AIS). The injury should preferably be described in the Abbreviated injury Scale code controlled vocabulary terms.",ALPHANUMERIC,,0,,,"{5,0,6,2,1,4,3}","{5,0,6,2,1,4,3}","{NULL,NULL,NULL,NULL,NULL,NULL,NULL}",,"For each body region, select the corresponding injury severity score.",,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AISInjSevScore,Abbreviated injury scale (AIS) - Injury severity score,CDE,1,"An injury severity score (AIS) code, as part of the Abbreviated injury scale (AIS) code","An injury severity score (AIS) code, as part of the Abbreviated injury scale (AIS) code",ALPHANUMERIC,,1,,,{NULL},{NULL},{NULL},,Enter the 6 digit predate code for every patient injury,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AISInjuryDesriptionTxt,Abbreviated injury scale (AIS) - injury clinical description text,CDE,1,"A clinical description of the subject injury(ies) from the medical documentation, as part of Abbreviated Injury Scale (AIS). The injury should preferably be described in the Abbreviated injury Scale code controlled vocabulary terms.","A clinical description of the subject injury(ies) from the medical documentation, as part of Abbreviated Injury Scale (AIS). The injury should preferably be described in the Abbreviated injury Scale code controlled vocabulary terms.",ALPHANUMERIC,,0,,,"{5,0,6,2,1,4,3}","{5,0,6,2,1,4,3}","{NULL,NULL,NULL,NULL,NULL,NULL,NULL}",,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AISInjurySeverityScore,Abbreviated injury scale (AIS) - Injury severity score,CDE,1,"An injury severity score (AIS) code, as part of the Abbreviated injury scale (AIS) code","An injury severity score (AIS) code, as part of the Abbreviated injury scale (AIS) code",ALPHANUMERIC,,1,,,"{5,0,6,2,1,4,3}","{5,0,6,2,1,4,3}","{NULL,NULL,NULL,NULL,NULL,NULL,NULL}",,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AISPreDot,Abbreviated Injury Score (AIS) - Predot,CDE,1,The abbreviated injury scale pre-dot codes that reflect the paitent's injuries,The abbreviated injury scale pre-dot codes that reflect the patient's injuries,ALPHANUMERIC,,0,,,"{5,0,6,2,1,4,3}","{5,0,6,2,1,4,3}","{NULL,NULL,NULL,NULL,NULL,NULL,NULL}",,"The subject's age is typically recorded to the nearest full year completed, e.g. 11 years and 6 months should be recorded as 11 years. For subject's which are under 1 year old, use decimal points and use the following convention- record 1 month as 0.083 (1/12), 2 months as 0.166 (2/12), 3 months as 0.25 (3/12), 4 months as 0.333 (4/12), 5 months as 0.416 (5/12), 6 months as 0.5 (6/12), 7 months as 0.583 (7/12), 8 months as 0.666 (8/12), 9 months as 0.75 (9/12), 10 months as 0.833 (10/12), 11 months as 0.916 (11/12) and 12 months as 1 year. For the individuals 90 or older, in order to preserve PII, please submit ""150"" and make a note this in the ""general notes"" column.",,,,No references available,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Armdscrptn,Arm description,CDE,1,"If needed, additional descriptive information (including which interventions are administered in each arm) to differentiate each arm from other arms in the clinical trial.","If needed, additional descriptive information (including which interventions are administered in each arm) to differentiate each arm from other arms in the clinical trial.",ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,Enter other data source text,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ArmGrpIntrvntCrssRf,Arm or group/interventional cross-reference,CDE,1,"If multiple Arms or Groups have been specified, indicate which Interventions (or exposures) are in each Arm or Group of the study, using the Cross-Reference check boxes.","If multiple Arms or Groups have been specified, indicate which Interventions (or exposures) are in each Arm or Group of the study, using the Cross-Reference check boxes.",ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Armttl,Arm title,CDE,1,The short name used to identify the arm.,The short name used to identify the arm.,ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ArmTyp,Arm type,CDE,1,The role of each arm in the clinical trial,The role of each arm in the clinical trial,ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,Select all that apply.,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Avlbltyexpndaccss,Availability of expanded access,CDE,1,"Whether there is expanded access to the investigational product for patients who do not qualify for enrollment in a clinical trial. Expanded Access for investigational drug products (including biological products) includes all expanded access types under section 561 of the Federal Food, Drug, and Cosmetic Act: (1) for individual participants, including emergency use; (2) for intermediate-size participant populations; and (3) under a treatment IND or treatment protocol.",Whether there is expanded access to the investigational product for patients who do not qualify for enrollment in a clinical trial.,ALPHANUMERIC,,1,,,"{unknown,yes,no}","{""Unknown If the responsible party is not the sponsor of the clinical trial and manufacturer of the investigational product"",""Yes Investigational product is available through expanded access"",""No Investigational product is not available through expanded access""}","{NULL,NULL,NULL}",,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
BAC,Blood Alcohol Level,UDE,1,Blood alcohol levelmeasurement,blood alcohol level measurement,NUMERIC,1000,0,0,1000,{NULL},{NULL},{NULL},,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Brdaffltn,Board affiliation,CDE,1,Official name of organizational affiliation of the approving human subjects review board.,Official name of organizational affiliation of the approving human subjects review board.,ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Brdapprvlnmum,Board approval number,CDE,1,Number assigned by the human subjects review board upon approval of the protocol. May be omitted if status is anything other than approved.,Number assigned by the human subjects review board upon approval of the protocol. May be omitted if status is anything other than approved.,ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Brdcntct,Board contact,CDE,1,Contact information for the human subjects review board.,Contact information for the human subjects review board.,ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Brdnme,Board name,CDE,1,Full name of the approving human subjects review board.,Full name of the approving human subjects review board.,ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Brfsmmry,Brief summary,CDE,1,"A short description of the clinical study, including a brief statement of the clinical study's hypothesis, written in language intended for the lay public.","A short description of the clinical study, including a brief statement of the clinical study's hypothesis, written in language intended for the lay public.",ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
BUN,BUN,UDE,1,Vaue of blood urea nitrogen,Vaue of blood urea nitrogen,NUMERIC,,0,,,{NULL},{NULL},{NULL},,"Choose one.  Response is obtained by report of the participant/subject or caretaker. If more detailed characterizations of ethnicity are collected to enhance data quality and consistency, it is recommended that they be ""collapsible"" up to the two categories for reportable ethnicity, as needed for reporting to FDA under its guidance. Other regulatory bodies may expect the reporting of ethnicity values which more appropriately reflect the population of their areas (e.g., Japanese ancestry for MHLW reporting to Japan). These may be collected as an extension to the suggested code list.",,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ChlorideLevel,Chloride Level,UDE,1,serum measurement of chloride,serum measurement of chloride,NUMERIC,,0,,,{NULL},{NULL},{NULL},,Use this field to capture additional information,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Cntry,Country,CDE,1,Country,Country,ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CO2,CO2,UDE,1,information related to measurement of the medical procedure that involves a measurement of the carbon dioxide gas in a biologicl specimen,information related to measurement of the medical procedure that involves a measurement of the carbon dioxide gas in a biologicl specimen,NUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Complication,Complications,CDE,1,The complications from care of the participant/subject,The complications from care of the participant/subject,ALPHANUMERIC,,2,,,"{6,13,2,9,4,8,17,3,10,15,21,14,5,16,1,19,12,7,18,11,20}","{""central line-associated bloodstream infection"",""pulmonary embolism"",""alochol withdrawal syndrome"",""extremity compartment syndrome"",""cardiac arrest with cardio pulmonary resusciation"",""deep vein thrombosis"",""superficial incisional surgical site infection"",ards,""myocardial infarction"",""severe sepsis"",other,""pressure ulcer"",""catheter-associated urinary tract infection"",""stroke/cerbrovascular accident"",""acute kidney injury"",""unplanned return to the operating room"",osteomyelitis,""deep surgical site infection"",""unplanned admission to ICU"",""organ/space surgical site infection"",""ventilator associated pneumonia""}","{NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL}",,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ComplicationOthr,Complications Other,CDE,1,Other complications,other complications,ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CTcmprssn,CT compression of basal cistern,UDE,1,Assessment of compression of basal cistern on CT Scan,Assessment of compression of basal cistern on CT Scan,ALPHANUMERIC,,1,,,"{2,5,1,3,4}","{no,improved,yes,worsen,stable}","{NULL,NULL,NULL,NULL,NULL}",,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CTcntsn,CT contusion,UDE,1,Assessment of contusion on CT Scan,Assessment of contusion on CT Scan,ALPHANUMERIC,,1,,,"{2,5,1,3,4}","{no,improved,yes,worsen,stable}","{NULL,NULL,NULL,NULL,NULL}",,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Ctedma,CT edema,UDE,1,Assessment of  brain edema on CT Scan,Assessment of  brain edema on CT Scan,ALPHANUMERIC,,1,,,"{2,5,1,3,4}","{no,improved,yes,worsen,stable}","{NULL,NULL,NULL,NULL,NULL}",,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Ctischmia,CT ischemia,UDE,1,Assessment of ischemia on CT Scan,Assessment of ischemia on CT Scan,ALPHANUMERIC,,1,,,"{2,5,1,3,4}","{no,improved,yes,worsen,stable}","{NULL,NULL,NULL,NULL,NULL}",,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CTmdlnshft,CT midline shift,UDE,1,Assessment of midline shift on CT Scan,Assessment of midline shift on CT Scan,ALPHANUMERIC,,1,,,"{2,5,1,3,4}","{no,improved,yes,worsen,stable}","{NULL,NULL,NULL,NULL,NULL}",,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Ctovrll,CT overall,UDE,1,Assessment of overall CT Scan,Assessment of overall CT Scan,ALPHANUMERIC,,1,,,"{3,1,2}","{improved,worsen,stable}","{NULL,NULL,NULL}",,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Cty,City,CDE,1,City,City,ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DataSource,Data Source,CDE,1,Source of the data provided on the case report form.,Source of the data provided on the case report form.,ALPHANUMERIC,,2,,,"{""Chart/medical record"",Unknown,Physician,Friend,Participant/subject,Son,Mother,""Family, specify relation"",""Other, specify"",Spouse,Brother,Sister,Daughter,Father}","{""Chart/Medical record"",Unknown,Physician,Friend,Participant/subject,Son,Mother,""Family, specify relation"",""Other, specify"",Spouse,Brother,Sister,Daughter,Father}","{2,999,9,5,8,11,6,444,777,12,1,10,3,4}",,,,Who is the source of this information in relation to the subject?,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DataSourceOTH,Data source other,CDE,1,The free-text field related to Data source specifying other text. Source of the data provided on the case report form,The free-text field related to Data source specifying other text. Source of the data provided on the case report form,ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,"Record as many as needed; please refer to http: //www.cdc.gov/nchs/icd.htm. Response is obtained from report by subject/participant (if possible), witnesses, first responders, family and/or medical records. The cause of injury is particularly important from an epidemiologic perspective, but may also be related to mechanism of injury and consequently type and extent of brain damage.ÃÂÃÂÃÂÃÂ ",,"Other, specify",,No references available,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DiaBloodPressr,Diastolic Blood Pressure,CDE,1,Measurement of pressure of the participant's/subject's blood against the artery walls during diastole (the relaxation phase) in millimeters of mercury (mmHg),Measurement of pressure of the participant's/subject's blood against the artery walls during diastole (the relaxation phase) in millimeters of mercury (mmHg),NUMERIC,300,0,0,300,{NULL},{NULL},{NULL},Millimeters of Mercury,,,,,No references available,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DISPO_ID,DISPO_ID,UDE,1,ID of disposition of patient,ID of disposition of patient,NUMERIC,23,0,1,23,"{23,7,10,8,4,3,16,17}","{23d,7,10,8,4,3,16,17}","{NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL}",,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
disposition,disposition,UDE,1,The disposition of the patient when discharged from the hospital,The disposition of the patient when discharged from the hospital,ALPHANUMERIC,,0,,,"{""residentail facility"",""inpatient rehab facility"",""inpatient outstate"",expired,""inpatient instate"",""subacute rehab facility"",""acute care""}","{""residentail facility"",""inpatient rehab facility"",""inpatient outstate"",expired,""inpatient instate"",""subacute rehab facility"",""acute care""}","{NULL,NULL,NULL,NULL,NULL,NULL,NULL}",,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Dspstion,Disposition,UDE,1,The disposition of the patient when discharged from the hospital,The disposition of the patient when discharged from the hospital,ALPHANUMERIC,,1,,,"{""Inpatient Instate"",""Inpatient Outstate"",""Acute Care"",""Subacute Rehab Facility"",Expired,""Home to services"",""Inpatient Rehab Facility"",""Home No Services"",""Residential Facility""}","{"""","""","""","""","""","""","""","""",""""}","{NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL}",,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Dspstn,Disposition,UDE,1,The disposition of the patient when discharged from the hospital,The disposition of the patient when discharged from the hospital,ALPHANUMERIC,,1,,,"{""Subacute Rehab"",""Inpatient Instate"",""Inpatient Outstate"",""Acute Care"",Expired,""Home to services"",""Inpatient Rehab"",""Residential Facility""}","{"""","""","""","""","""","""","""",""""}","{NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL}",,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
dspstn,Disposition,UDE,1,The disposition of the patient when discharged from the hospital,The disposition of the patient when discharged from the hospital,ALPHANUMERIC,,1,,,"{""Inpatient Instate"",""Inpatient Outstate"",""Acute Care"",""Subacute Rehab Facility"",Expired,""Home to services"",""Inpatient Rehab Facility"",""Residential Facility""}","{"""","""","""","""","""","""","""",""""}","{NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL}",,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ECodeTxt,Ecode Text Description,UDE,1,Description of mechani+B14+D14,Description of mechanism of injury based upon Ecode,ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EDArrivalDateTime,ED Admit Date and Time,CDE,1,Date and time the particpant arrived at the Emergency Department,Date and time the particpant arrived at the Emergency Department,DATE,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EDDschrgDispo,ED Disposition,CDE,1,The disposition of the participant when discharged from the ED,The disposition of the participant when discharged from the ED,ALPHANUMERIC,,2,,,"{11,2,6,5,7,9,1,4,8,3,10}","{""transferred to another hospital"",""observation unit"",other,deceased/expired,""operating room"",""home without services"",""floor bed"",""home with services"",""intensive care unit"",""telemetry/step-down unit"",""left against medical advice""}","{NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL}",,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EDDschrgDispoOthr,ED Disposition Other,CDE,1,The discharge location if Other chosen above,The discharge location if Other chosen above,ALPHANUMERIC,,1,,,"{1,3,2}","{jail,""mental health"",""instutional care""}","{NULL,NULL,NULL}",,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Elgblty_crtra,Eligibility-criteria,CDE,1,"A limited list of criteria for selection of participants in the clinical study, provided in terms of inclusion and exclusion criteria and suitable for assisting potential participants in identifying clinical studies of interest. Use a bulleted list for each criterion below the headers ""Inclusion Criteria"" and ""Exclusion Criteria"".","A limited list of criteria for selection of participants in the clinical study, provided in terms of inclusion and exclusion criteria and suitable for assisting potential participants in identifying clinical studies of interest.",ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Elgblty_gndrbsd,Eligibility-gender based,CDE,1,"If applicable, indicate whether participant eligibility is based on gender.","If applicable, indicate whether participant eligibility is based on gender.",ALPHANUMERIC,,1,,,"{2,1}","{no,yes}","{NULL,NULL}",,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Elgblty_maxage,Eligibility-maximum age,CDE,1,"The numerical value, if any, for the maximum age a potential participant can be to be eligible for the clinical study.","The numerical value, if any, for the maximum age a potential participant can be to be eligible for the clinical study.",NUMERIC,999999,0,0,999999,{NULL},{NULL},{NULL},,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Elgblty_minage,Eligibility-minimum age,CDE,1,"The numerical value, if any, for the minimum age a potential participant must meet to be eligible for the clinical study.","The numerical value, if any, for the minimum age a potential participant must meet to be eligible for the clinical study.",NUMERIC,999999,0,0,999999,{NULL},{NULL},{NULL},,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Elgblty_sx,Eligibility-sex,CDE,1,The sex of the participants eligible to participate in the clinical study.,The sex of the participants eligible to participate in the clinical study.,ALPHANUMERIC,,1,,,"{3,2,1}","{""Indicates that only male participants are being studied"",""Indicates that only female participants are being studied"",""Indicates no limit on eligibility based on the sex of participants""}","{NULL,NULL,NULL}",,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Elgblty_sxgndr,Eligibility-sex/gender,CDE,1,"The sex and, if applicable, gender of the participants eligible to participate in the clinical study.","The sex and, if applicable, gender of the participants eligible to participate in the clinical study.",ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Elgblty_unttme,Eligibiity-unit of time,CDE,1,The unit of time in which the age is measured,The unit of time in which the age is measured,ALPHANUMERIC,,1,,,"{5,4,1,6,2,3,7}","{hours,days,years,minutes,months,weeks,n/a}","{NULL,NULL,NULL,NULL,NULL,NULL,NULL}",,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Emladdrss,Email address,CDE,1,electronic mail address of the central contact person,electronic mail address of the central contact person,ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Enrllmnt,Enrollment,CDE,1,The estimated total number of participants to be enrolled (target number) or the actual total number of participants that are enrolled in the clinical study.,The estimated total number of participants to be enrolled (target number) or the actual total number of participants that are enrolled in the clinical study.,NUMERIC,1000000,0,0,1000000,{NULL},{NULL},{NULL},,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EthnUSACat,Ethnicity USA Category,CDE,1,Category of ethnicity the participant/subject most closely identifies with,Category of ethnicity the participant/subject most closely identifies with,ALPHANUMERIC,,1,,,"{""Not Hispanic or latino"",""Hispanic or Latino"",Unknown,""Not reported""}","{""2=A person not meeting the definition for Hispanic or Latino."",""1=A person of Cuban, Mexican, Puerto Rican, South or Central American, or other Spanish culture or origin, regardless of race.  The term \""Spanish origin\""� can also be used in addition to \""Hispanic or Latino.\"""",""999= not be determined or unsure"",""3=Not provided or available""}","{2,1,999,3}",,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Expndaccss_NCTnum,Expanded access NCT number,CDE,1,"If expanded access is available, the NCT number of the expanded access record. If there is no existing expanded access record, the responsible party who is both the manufacturer of the investigational drug product (including a biological product) and the sponsor of the ACT is required to create an expanded access record.","If expanded access is available, the NCT number of the expanded access record.",ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Face_AIS,Face AIS,UDE,1,AIS severity of injury for this body region,AIS severity of injury for this body region,NUMERIC,,1,,,"{5,6,2,1,4,3}","{5,6,2,1,4,3}","{NULL,NULL,NULL,NULL,NULL,NULL}",,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FDAcntr,FDA center,CDE,1,The name or abbreviation of the FDA Center with which the IND or IDE is filed.,The name or abbreviation of the FDA Center with which the IND or IDE is filed.,ALPHANUMERIC,,1,,,"{CBER,CDER,CDRH}","{""Center for BiologicsEvaluation and Research"",""Center for Drug Evaluation and Research"",""Center for Devices and Radiological Health""}","{NULL,NULL,NULL}",,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Fibrinogen,Fibrinogen,UDE,1,serum measurement of fibrinogen,serum measurement of fibrinogen,NUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ft2fly,Fit to Fly Assessment,UDE,1,Assessment of patients ability to endure a long distance air evacuation in last 6 hours,Assessment of subjects ability to endure a long distance air evacuation in last 6 hours,ALPHANUMERIC,,1,,,"{2,1,3}","{no,yes,n/a}","{NULL,NULL,NULL}",,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ft2fly2,Fit to Fly Assessment #2,UDE,1,Assessment of patients ability to endure a long distance air evacuation in last 6 hours,Assessment of subjects ability to endure a long distance air evacuation in last 6 hours,ALPHANUMERIC,,1,,,"{6,4,5,2,3,1}","{""n/a no assessment available"",agree,""strongly agree"",disagree,unsure,""strongly disagree""}","{NULL,NULL,NULL,NULL,NULL,NULL}",,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GCS,Glasgow Coma Score (GCS) - total score,CDE,1,"The GCS is a standardized instrument for assessing the level of consciousness. It evaluates three aspects of responsiveness: eye opening, motor response, verbal response. The total score is the sum of the scores for the three response types.",Total GCS,NUMERIC,17,0,3,17,"{15,14,13,9,12,16,17,5,6,7,10,8,11,4,3}","{15,14,13,9,12,untestable,unknown,5,6,7,10,8,11,4,3}","{NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL}",,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GCSe,Glasgow Coma Score (GCS) - eye response scale,CDE,1,Score that describes the participant's eye response according to the Glasgow Coma Scale (GCS),Assessment of eye response,NUMERIC,,1,,,"{3,2,4,5,6,1}","{""eye opening to speech/verbal command"",""eye opening to pain"",""eyes open spontaneously"",untestable,unknown,""no eye opening""}","{NULL,NULL,NULL,NULL,NULL,NULL}",,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GCSm,Glasgow Coma Score - motor response scale,CDE,1,Score that describes the participant's motor response according to the Glasgow Coma Scale (GCS),Assessment of motor response,NUMERIC,,1,,,"{5,3,4,8,2,7,1,6}","{""localizes pain"",""abnormal flexion"",""flexion withdrawal/withdraws from pain"",unknown,""abnormal extension/extensor response"",untestable,""no motor response"",""obeys command""}","{NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL}",,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GCSq,Glasgow Coma Score - Qualifier,CDE,1,Documentation of factors potentially affecting GCS eye or verbal,Documentation of factors potentially affecting GCS,NUMERIC,,1,,,"{2,3,4,1}","{""obstruction to the patient's eye"",""patient intubated"",""valid GCS: patient was not sedated, not intubated, and did not have obstruction to the eye"",""patient chemically sedated or paralyzed""}","{NULL,NULL,NULL,NULL}",,,,,,No references available,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GCSv,Glasgow Coma Score (GCS) - verbal response scale,CDE,1,Score that descirbes the participant's verbal response according to the Glasgow Coma Scale (GCS),Assessment of verbal response,NUMERIC,,1,,,"{2,4,5,1,7,3,6}","{""incomprehensible sound"",confused,oriented,""no verbal response/sounds"",unknown,""inappropriate words"",untestable}","{NULL,NULL,NULL,NULL,NULL,NULL,NULL}",,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Gender,Gender Code,CDE,1,The code representing the gender of a person,The code representing the gender of a person,ALPHANUMERIC,,1,,,"{Male,Female,Unknown,""not specified""}","{""2=Male a person who belongs to the sex that normally produces sperm"",""1=female a person who belongs to the sex that normally produces ova"",""999=unkown not known, not observed, not recorded or refused"",""3=not specified not stated explicity or in detail""}","{2,1,999,3}",,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GeneralNotesTxt,General notes text,CDE,1,General notes,General notes,ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,"Choose all that apply.  Response is obtained by report of the participant/subject or caretaker.  Collecting information on race may not be allowed in some countries for concerns related to discrimination. In other countries, however, these concerns are considered a reason for recording race in order to guarantee equal access to care. Investigators receiving funding from the US National Institutes of Health (NIH) are required to report the number of subjects enrolled on an annual basis using the racial categories listed.",,Additional information (if any):,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GlucoseLevel,Glucose Level,UDE,1,serum measurement of glucose,serum measurement of glucose,NUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GOSE,Glasgow Outcome Scale Extended,UDE,1,Glasgow Outcome Scale Extended,Glasgow Outcome Scale Extended,ALPHANUMERIC,,1,,,"{7,9,5,3,1,10,8,2,4,6}","{""lower good recover"",""clinic notes present but insufficient data to score"",""lower moderate disability"",""lower severe disability"",dead,""no appointment"",""upper good recovery"",""vegetative state"",""upper severe disability"",""upper moderate disability""}","{NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL}",,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Grpchrt_dscrptn,Group/cohort description,CDE,1,Explanation of the nature of the study group,Explanation of the nature of the study group,ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,Enter the name of the study site,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Grpchrt_lbl,Group/cohort label,CDE,1,The short name used to identify the group.,The short name used to identify the group.,ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Head_AIS,Head AIS,UDE,1,AIS severity of injury for this body region,AIS severity of injury for this body region,NUMERIC,,1,,,"{5,6,2,1,4,3}","{5,6,2,1,4,3}","{NULL,NULL,NULL,NULL,NULL,NULL}",,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HeartRate,Heart Rate,CDE,1.1,The participants/subjects pulse or number of contractions (heart beats)  per minute.,The participants/subjects heart rate measured in beats per minute.,NUMERIC,300,0,0,300,{NULL},{NULL},{NULL},Beats per minute,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HGB,HGB,UDE,1,serum measurement of hemoglobin,serum measurement of hemoglobin,NUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HgtMeasr,Height Measurement,CDE,1,Measurement of participant's/subject's height,Measurement of participant's/subject's height,NUMERIC,400,0,0,400,{NULL},{NULL},{NULL},Centimeter,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Hmnsubj_rvwbrdstats,Human subjects protection review board status,CDE,1,Indicate whether a clinical study has been reviewed and approved by at least one human subjects protection review board or such review is not required per applicable law,Indicate whether a clinical study has been reviewed and approved by at least one human subjects protection review board or such review is not required per applicable law,ALPHANUMERIC,,1,,,"{""Request not yet submitted"",""Submitted denied"",""Submission not required per applicable law"",""Submitted pending"",""Submitted approved"",Exempt}","{""Review board approval is required but has not yet been requested"",""Review board has denied the approval request"",""Review board approval is not required because the study is not subject to laws, regulations, or applicable institutional policies requiring human subjects review"",""Review board approval has been requested but not yet granted"",""Review board approval has been requested and obtained"",""An exemption in accord with applicable law and regulation has been granted""}","{NULL,NULL,NULL,NULL,NULL,NULL}",,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HospAdmitDateTime,Hospital Admit Date and Time,CDE,1,Date and time the particpant is admitted to the hospital,Date and time the particpant is admitted to the hospital,DATE,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HospDschrgDate,Hospital Discharge Date,CDE,1,The date the participant/subject was discharged from the hospital,The date the participant/subject was discharged from the hospital,DATE,,0,,,{NULL},{NULL},{NULL},,Enter the Unique Identifier created by the NTRR system (Pseudo GUID or GUID),,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HospDschrgDispo,Hospital Discharge Disposition,CDE,1,The disposition of the participant/subject when discharged frm the hospital,The disposition of the participant/subject when discharged frm the hospital,ALPHANUMERIC,,1,,,"{7,5,1,2,11,4,10,6,9,12,13,3,8}","{""discharged/transferred to skilled nursing facility"",deceased/expired,""discharged/tranferred to a short-term general hospital for inpatient care"",""discharged/transferred to an intermediate care facility"",""discharged/transferred to long term care hospital"",""left against medical advice or discontinued care"",""discharged/transferred to inpatient rehab or designated unit"",""discharged to home or self-care"",""discharged/transferred to court/law enforcement"",""discharged/transferred to psychiatric hospital or psychiatric distinct part unit of a hospital"",""discharged/transferred to another type of institution not defined elsewhere"",""discharged/transferred to home under care of organized home health service"",""discharged/transferred to hospice care""}","{NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL}",,"Record the date/time according to the ISO 8601, the International Standard for the representation of dates and times (http://www.iso.org/iso/home.html). The date/time should be recorded to the level of granularity known (e.g., year, year and month, complete date plus hours and minutes, etc.). Data Sharing Instructions: When date/time data are prepared for aggregation or sharing they should be converted to the format specified by ISO 8601, YYYY-MM-DDThh:mm:ss",,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HospLOS,Hosp LOS,UDE,1,The cumulative amount of time spent in the hospital. Each partial or full day should be measured as one calendar day.,The cumulative amount of time spent in the hospital. Each partial or full day should be measured as one calendar day.,NUMERIC,1000,0,0,1000,{NULL},{NULL},{NULL},,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HR,Heart Rate,CDE,1,The participants/subjects pulse or number of contractions (heart beats)  per minute.,The participants/subjects heart rate measured in beats per minute.,NUMERIC,300,0,0,300,{NULL},{NULL},{NULL},Beats per minute,The participant or subject identifiers or IDs should be assigned by the study.,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ICDVersion,International Classification of Disease Version,CDE,1,A version of the International Classification of Disease coding system,A version of the International Classification of Diseases coding system,ALPHANUMERIC,,1,,,"{ICD-10,ICD-9-CM}","{ICD-10,ICD-9-CM}","{2,1}",,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ICU_Days,ICU Days,UDE,1,The cumulative amount of time spent in the ICU. Each partial or full day should be measured as one calender day,The cumulative amount of time spent in the ICU. Each partial or full day should be measured as one calender day,NUMERIC,1000,0,0,1000,{NULL},{NULL},{NULL},,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
IND_IDE,U.S. Food and Drug Administration IND or IDE,CDE,1,Indicate whether the clinical study is being conducted under an IND or IDE application filed with the FDA.,Indicate whether the clinical study is being conducted under an IND or IDE application filed with the FDA.,ALPHANUMERIC,,1,,,"{no,yes}","{""Clinical study is not conducted under an IND or IDE filed with the FDA. Includes a clinical study that is �IND exempt� under FDA regulations in 21 CFR 312.2(b), or is for a nonsignificant risk device subject to FDA-abbreviated IDE requirements in 21 CFR 812.2(b), or is exempt from the IDE filing requirements in 21 CFR 812."",""Yes Clinical study is conducted under an IND or IDE filed with the FDA""}","{NULL,NULL}",,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
IND_IDEnum,IND or IDE number,CDE,1,IND or IDE number assigned by the FDA Center.,IND or IDE number assigned by the FDA Center.,ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INDsrlnum,IND serial number,CDE,1,"For an IND, the IND serial number, as defined in 21 CFR 312.23(e), if any, assigned to the clinical study.","For an IND, the IND serial number, as defined in 21 CFR 312.23(e), if any, assigned to the clinical study.",ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Indvstestats,Individual site status,CDE,1,The recruitment status of each participating facility in a clinical study.,The recruitment status of each participating facility in a clinical study.,ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Inj_Type_id,Inj Type id,UDE,1,Diagnosis related to all identified injuries,Diagnosis related to all identified injuries,NUMERIC,,1,,,{NULL},{NULL},{NULL},,,,Code to classify the external cause of the injury,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
InjICDExtCauseCode,Injury ICD external cause code,CDE,1,Code to classify the external cause of injury,Code to classify the external cause of injury,ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
InjryDscrptn,Injury Description,UDE,1,Injury Description,Injury Description,ALPHANUMERIC,,0,,,"{Blunt,Penetrating}","{""blunt injury mechanism "",""penetrating injury mechanism""}","{NULL,NULL}",,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
InjryTypDscrptn,Injury Type Descrip,UDE,1,Type of injury,Type of injury,ALPHANUMERIC,,1,,,"{1,2}","{blunt,penetrating}","{NULL,NULL}",,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
InjuryTypeDescrip,Injury Type Descrip,UDE,1.1,Type of injury,Type of injury,ALPHANUMERIC,,1,,,"{1,2}","{blunt,penetrating}","{NULL,NULL}",,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INR,INR,UDE,1,serum measuremtn of INR,serum measuremtn of INR,NUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Intrvntnm_othr,Other intervention name(s),CDE,1,"Other current and former name(s) or alias(es), if any, different from the Intervention Name(s), that the sponsor has used publicly to identify the intervention(s), including, but not limited to, past or present names such as brand name(s), or serial numbers.","Other current and former name(s) or alias(es), if any, different from the Intervention Name(s), that the sponsor has used publicly",ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Intrvntnme,Intervention name(s),CDE,1,A brief descriptive name used to refer to the intervention(s) studied in each arm of the clinical study.,A brief descriptive name used to refer to the intervention(s) studied in each arm of the clinical study.,ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Intrvnts,Interventions,CDE,1,Specify the intervention(s) associated with each arm or group,Specify the intervention(s) associated with each arm or group,ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Intrvnttyp,Intervention type,CDE,1,"For each intervention studied in the clinicl study, the general type of intervention","For each intervention studied in the clinical study, the general type of intervention.",ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
IntubatedAdmGcs,Intubated adm gcs,UDE,1,Adm GCS on intubated patient,Adm GCS on intubated patient,NUMERIC,,1,,,"{0,1}","{0,1}","{NULL,NULL}",,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Invstgtrinfo,Investigator information,CDE,1,"If the Responsible Party, by Official Title is either ""Principal Investigator"" or ""Sponsor-Investigator,"" the following is required","If the Responsible Party, by Official Title is either ""Principal Investigator"" or ""Sponsor-Investigator,"" the following is required",ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ISS,Injury Severity Score,CDE,1,Score measured by injury severity score (ISS),Score measured by injury severity score (ISS),NUMERIC,75,0,1,75,{NULL},{NULL},{NULL},,,,ISS,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LactateWB,Lactate WB,UDE,1,serum measurement of lactate,serum measurement of lactate,NUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LE_AIS,Lower Extremity AIS,UDE,1,AIS severity of injury for this body region,AIS severity of injury for this body region,NUMERIC,,1,,,"{5,6,2,1,4,3}","{5,6,2,1,4,3}","{NULL,NULL,NULL,NULL,NULL,NULL}",,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lstnme,Last name or official title,CDE,1,"The name or title, toll-free telephone number and email address of a person to whom questions concerning enrollment at any location of the study can be addressed.","The name or title, toll-free telephone number and email address of a person to whom questions concerning enrollment at any location of the study can be addressed.",ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MrshllScre,Marshall Score,UDE,1,CT scan derived metric using only a few features used to predict outcome in patients with traumatic brain injury.,CT scan derived metric using only a few features used to predict outcome in patients with traumatic brain injury.,ALPHANUMERIC,,1,,,"{7,9,10,4,16,3,11,8,5,12,13,17,2,18,1,15,6,14}","{""3 Diffuse Injury III swelling"",""5 Evacuated mass lesion"",""5A Evacuated mass lesion extradural"",""2B Diffuse Injury II 1 lesion"",""6B non evacuated mass lesions subdural"",""2A Diffuse Injury II no lesion"",""5B Evacuated mass lesion subdural"",""4 Diffuse Injury IV shift"",""2C Diffuse Injury II >=2 unilateral lesion"",""5C Evacuated mass lesion intracerebral"",""5D Evacuated mass lesion >=2 intra + extra"",""6C non evauated mass lesion intracerebral"",""2 Diffuse Injury II"",""6D non evacuated mass lesions =2 intra+extra"",""1 Diffuse Injury I no visible pathology, negative CT"",""6A non evacuated mass lesions extradural"",""2D Diffuse Injury II bilateral lesions"",""6 Non evauated mass lesion""}","{NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL}",,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Ndfr_Intrvntion,Need for Intervention,UDE,1,Need for internvention,Need for intervention,ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NdfrIntvntn,Need for Intervention,UDE,1,Need for internvention,Need for intervention,ALPHANUMERIC,,2,,,"{13,8,15,2,5,12,10,14,11,4,9,6,3,7,1}","{""subdural drainage catheter"",""IR procedure"",ventriculostomy,""camino changed to ivc"",""evd placement"",""OR for trauma surgery"",OR,v/crani,""OR for craniotomy"",craniotomy,ive,intubate,craniectmy,""IR for emboli"",camino}","{NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL}",,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Neck_AIS,Neck AIS,UDE,1,AIS severity of injury for this body region,AIS severity of injury for this body region,NUMERIC,,1,,,"{5,6,2,1,4,3}","{5,6,2,1,4,3}","{NULL,NULL,NULL,NULL,NULL,NULL}",,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Numgrps_chrts,Number of groups/cohorts,CDE,1,Number of study groups/cohorts.,Number of study groups/cohorts.,NUMERIC,5,0,1,5,{NULL},{NULL},{NULL},,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
O2Sat,Oxygen Saturation,UDE,1,"Value, as a percent, of baseline O2 saturation (SPO2) in nocturnal oximetry",First recorded oxygen saturation in the hospital within 30 minutes or less of hospital arrival,NUMERIC,100,0,0,100,{NULL},{NULL},{NULL},,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Obsrvtnlstdymdl,Observational study model,CDE,1,Primary strategy for participant identification and follow-up.,Primary strategy for participant identification and follow-up,ALPHANUMERIC,,1,,,"{4,6,1,5,2,3}","{""Case-Crossover Characteristics of case immediately prior to disease onset (sometimes called the hazard period) compared to characteristics of same case at a prior time"",""otherFamily-Based: Studies conducted among family members, such as genetic studies within families or twin studies and studies of family environment. Other: Explain in Detailed Description."",""Cohort Group of individuals, initially defined and composed, with common characteristics who are examined or traced over a given time period"",""Ecologic or Community Studies Geographically defined populations, such as countries or regions within a country, compared on a variety of environmental (for example, air pollution intensity, hours of sunlight) and/or global measures not reducible to individual level characteristics (for example, healthcare system, laws or policies median income, average fat intake, disease rate)."",""Case-Control Group of individuals with specific characteristics (for example, conditions or exposures) compared to group(s) with different characteristics, but otherwise similar"",""Case-Only Single group of individuals with specific characteristics""}","{NULL,NULL,NULL,NULL,NULL,NULL}",,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Obsrvtnlstdymdl_othr,Observational study model - other,CDE,1,Observational Study Model - Other Description,Observational Study Model - Other Description,ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
OtsdeCT,Outside CT Scan,UDE,1,CT scan performed at outside facility,CT scan performed at outside facility,ALPHANUMERIC,,1,,,"{2,1}","{no,yes}","{NULL,NULL}",,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Ovrllrcrtmntstats,Overall recruitment status,CDE,1,"The recruitment status for the clinical study as a whole, based upon the status of the individual sites. If at least one facility in a multi-site clinical study has an Individual Site Status of ""Recruiting,"" then the Overall Recruitment Status for the study must be ""Recruiting.""",Recruitment status for the study as a whole,NUMERIC,,1,,,"{2,7,3,4,5,1,8,6}","{""2 Participants are currently being recruited, whether or not any participants have yet been enrolled"",""7 Study halted prematurely and will not resume, participants are no longer being examined or receiving intervention"",""3 Participants are being (or will be) selected from a predetermined population"",""4  Study is continuing, meaning participants are receiving an intervention or being examined, but new participants are not currently being recruited or enrolled"",""5 The study has concluded normally"",""1 Participants are not yet being recruited"",""8 study halted prematurely, prior to enrollment of first participantWithdrawn: Study halted prematurely, prior to enrollment of first participant"",""6 Study halted prematurely but potentially will resume""}","{NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL}",,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PartialThromboplastinTime,Partial Thromboplastin Time,UDE,1,serum measurement of partial thromboplastin time,serum measurement of partial thromboplastin time,NUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Pdtrcpstmrkt_srvllnce,Pediatric postmarket surveillance of a device product,CDE,1,"Indication that a clinical study that includes a U.S. FDA-regulated device product is a pediatric postmarket surveillance of a device product ordered under section 522 of the Federal Food, Drug, and Cosmetic Act.","Indication that a clinical study that includes a U.S. FDA-regulated device product is a pediatric postmarket surveillance of a device product ordered under section 522 of the Federal Food, Drug, and Cosmetic Act.",ALPHANUMERIC,,1,,,"{no,yes}","{""no study does not include postmarket surveillance of a device product"",""yes study includes postmarket surveillance of a device product""}","{NULL,NULL}",,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Person_Sex,Person Sex,CDE,1,The assemblage of physical properties or qualities by which male is distinguished from female,The assemblage of physical properties or qualities by which male is distinguished from female,ALPHANUMERIC,,1,,,"{A,M,F,U}","{""A rare congenital abnormality in which the infant's external genitalia do not have the typical appearance of a male's or female's genitalia."",""A person who belongs to the sex that normally produces sperm. The term is used to indicate biological sex distinctions, cultural gender role distinctions, or both."",""A person who belongs to the sex that normally produces ova. The term is used to indicate biological sex distinctions, or cultural gender role distinctions, or both."",""Not known, not observed, not recorded, or refused.""}","{NULL,NULL,NULL,NULL}",,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHIntrvtns,PreHospital Interventions,CDE,1,Interventions performed in the PreHospital setting,Prehospital interventions,ALPHANUMERIC,,2,,,"{Tourniquet,AED,None,CPR,Other,Unknown}","{Tourniquet,AED,None,CPR,Other,Unknown}","{NULL,NULL,NULL,NULL,NULL,NULL}",,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Phnnum,Phone number,CDE,1,"Toll free phone number of the Central Contact Person. Use the format 800-555-5555 within the United States and Canada. If outside the United States and Canada, provide the full phone number, including the country code.","Toll free phone number of the Central Contact Person. Use the format 800-555-5555 within the United States and Canada. If outside the United States and Canada, provide the full phone number, including the country code.",ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Platelet,Platelet,UDE,1,total patlet count value,total patlet count value,NUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PotassiumLevel,Potassium Level,UDE,1,serum measurement of potassium,serum measurement of potassium,NUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PrdctmnfctdUSA,Product manufactured in and exported from the US,CDE,1,"Whether any drug product (including a biological product) or device product studied in the clinical study is manufactured in the United States or one of its territories and exported for study in a clinical study in another country. Required if U.S. FDA-regulated Drug and/or U.S. FDA-regulated Device is ""Yes,"" U.S. FDA IND or IDE is ""No"", and Facility Information does not include at least one U.S. location.",Whether any drug product (including a biological product) or device product studied in the clinical study is manufactured in the United States or one of its territories and exported for study in a clinical study in another country.,ALPHANUMERIC,,1,,,"{no,yes}","{""no product not manufactured or exported from the US"",""yes product manufactured or exported in the US""}","{NULL,NULL}",,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Prmrycmpltndte,Primary completion date,CDE,1,"The date that the final participant was examined or received an intervention for the purposes of final collection of data for the primary outcome, whether the clinical study concluded according to the pre-specified protocol or wasThe date that the final participant was examined or received an intervention for the purposes of final collection of data for the primary outcome, whether the clinical study concluded according to the pre-specified protocol or was terminated. In the case of clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all of the primary outcomes.  terminated. In the case of clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all of the primary outcomes.",The date that the final participant was examined or received an intervention for the purposes of final collection fo data for the primary outcomes.,DATE,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Prmrydsse_cndtn,Primary disease or condition,CDE,1,"Primary disease or condition being studied in the trial, or the focus of the study","The name(s) of the disease(s) or condition(s) studied in the clinical study, or the focus of the clinical study.",ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Prmryotcmmeasr_dscrptn,Primary outcome measure description,CDE,1,"Description of the metric used to characterize the specific primary outcome measure, if not included in the primary outcome measure title.","Description of the metric used to characterize the specific primary outcome measure, if not included in the primary outcome measure title.",ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Prmryotcmmeasr_tmfrm,Primary outcome measure timeframe,CDE,1,Time point(s) at which the measurement is assessed for the specific metric used. The description of the time point(s) of assessment must be specific to the outcome measure and is generally the specific duration of time over which each participant is assessed (not the overall duration of the study).,Time point(s) at which the measurement is assessed for the specific metric used.,ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Prmryotcmmeasr_ttl,Primary outcome measure title,CDE,1,Name of the specific primary outcome measure,Name of the specific primary outcome measure,ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Protime,Protime,UDE,1,serum measurement of protime,serum measurement of protime,NUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Prtclidnum,Protocol identification number,CDE,1,Any unique identifying assigned to the protocol by the sponsor.,Any unique identifying assigned to the protocol by the sponsor.,ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PstMdHxCrdcDsse,Past medical history - Cardiac disease,UDE,1,Past medical history of the subject includes cardiac disease,Past medical history of the subject includes cardiac disease,ALPHANUMERIC,,1,,,"{4,1,2,3}","{""coronary artery disease"",""cardiac dysrhythmia"",""acute myocardial infarction (<12mo)"",""congestive heart failure""}","{NULL,NULL,NULL,NULL}",,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PstMdHxEndcneDsse,Past medical history - Endocrine disease,UDE,1,Past medical history of the subject includes endocrine disease,Past medical history of the subject includes endocrine disease,ALPHANUMERIC,,1,,,"{2,1}","{""diabetes insulin dependent"",""diabetes mellitus NFS""}","{NULL,NULL}",,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PstMdHxHemDsse,Past medical history - hematologic disease,UDE,1,Past medical history of the subject includes hematolgic disease,Past medical history of the subject includes hematologic disease,ALPHANUMERIC,,1,,,{1},"{""coumadin therapy""}",{NULL},,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PstMdHxLvrDsse,Past medical history - liver disease,UDE,1,Past medical history of the subject includes liver disease,Past medical history of the subject includes liver disease,ALPHANUMERIC,,1,,,{1},{hepatitis},{NULL},,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PstMdHxMlgncy,Past medical history - malignancy,UDE,1,Past medical history of the subject includes malignancy,Past medical history of the subject includes malignancy,ALPHANUMERIC,,1,,,"{1,2}","{lymphoma,other}","{NULL,NULL}",,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PstMdHxNerodsse,Past medical history - neurological disease,UDE,1,Past medical history of the subject includes neurological disease,Past medical history of the subject includes neurological disease,ALPHANUMERIC,,1,,,"{3,2,1}","{""other brain development issues"",depression,""bipolar affective disorder""}","{NULL,NULL,NULL}",,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PstMdHxNne,Past medical history - None,UDE,1,Subject has no past medical history,Subject has no past medical history,ALPHANUMERIC,,1,,,{1},{none},{NULL},,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PstMdHxOthr,Past medical history - other,UDE,1,Past medical history of the subject includes other than list,Past medical history of the subject includes other than list,ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PstMdHxPstSrgry,Past medical history - past surgery,UDE,1.1,Past medical history of the subject includes past surgeries,Past medical history of the subject includes past surgeries,ALPHANUMERIC,,1,,,"{2,3,1,4,5}","{""Cardiac Surgery"",Cholecystectomy,Appendectomy,C-Section,Other}","{NULL,NULL,NULL,NULL,NULL}",,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PstMdHxRsprtryDsse,Past medical history - respiratory disease,UDE,1,Past medical history of the subject includes respriatory disease,Past medical history of the subject includes respiratory disease,ALPHANUMERIC,,1,,,"{1,2}","{""asthma on bronchodilator"",""ashtma NSFS""}","{NULL,NULL}",,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PstMdhxSclHx,Past medical history - social history,UDE,1,Past medical history of the subject includes social history,Past medical history of the subject includes social history,ALPHANUMERIC,,1,,,"{5,2,4,7,6,1,3}","{""non=intravenous drug abuse disorder"",ADD/ADHS,""intravenous drug abuse disorder"",""unspecified drug dependence disorder"",""tobacco use"",""alcohol dependence/disorder"",""Do not resuscitate""}","{NULL,NULL,NULL,NULL,NULL,NULL,NULL}",,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PstMdHxThydDsse,Past medical history - thyroid disease,UDE,1,Past medical history of the subject includes thyroid disease,Past medical history of the subject includes thyroid disease,ALPHANUMERIC,,1,,,{1},{hypothyroidism},{NULL},,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PstMdHxVsclrDsse,Past medical hsitory - vascular disease,UDE,1,Past medical history of the subject includes vascular disease,Past medical history of the subject includes vascular disease,ALPHANUMERIC,,1,,,"{1,2}","{""deep vein thrombosis"",hypertension}","{NULL,NULL}",,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PstMedHxCrdcDsse,Past medical history - Cardiac disease,UDE,1,Past medical history of the subject includes cardiac disease,Past medical history of the subject includes cardiac disease,ALPHANUMERIC,,2,,,"{""Coronary Artery Disease"",""Cardiac dysrhythmia"",""Acute Myocardial Infarction ( < 12 mo.)"",""Congestive Heart Failure""}","{""Coronary artery disease"",""Cardiac dysrhythmia"",""Acute myocardial infarction (<12mo)"",""Congestive heart failure""}","{NULL,NULL,NULL,NULL}",,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PstMedHxEndcneDsse,Past medical history - Endocrine disease,UDE,1,Past medical history of the subject includes endocrine disease,Past medical history of the subject includes endocrine disease,ALPHANUMERIC,,2,,,"{""Diabetes Mellitus NFS"",""Diabetes, insulin dependent""}","{""Diabetes Mellitus NFS"",""Diabetes, insulin dependent""}","{NULL,NULL}",,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PstMedHxHemDsse,Past medical history - Hematologic disease,UDE,1,Past medical history of the subject includes hematolgic disease,Past medical history of the subject includes hematologic disease,ALPHANUMERIC,,2,,,"{""Coumadin Therapy""}","{""Coumadin Therapy""}",{NULL},,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PstMedHxLvrDsse,Past medical history - Liver disease,UDE,1,Past medical history of the subject includes liver disease,Past medical history of the subject includes liver disease,ALPHANUMERIC,,2,,,"{""Hepatitis, unspecified (a.b.c)""}",{hepatitis},{NULL},,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PstMedHxMlgncy,Past medical history - Malignancy,UDE,1,Past medical history of the subject includes malignancy,Past medical history of the subject includes malignancy,ALPHANUMERIC,,2,,,"{Lymphomas,""Other Malignancy""}","{lymphoma,other}","{NULL,NULL}",,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PstMedHxNerodsse,Past medical history - Neurological disease,UDE,1,Past medical history of the subject includes neurological disease,Past medical history of the subject includes neurological disease,ALPHANUMERIC,,2,,,"{""Bipolar affective disorder"",Depression,""Other brain development issues""}","{""bipolar affective disorder"",depression,""other brain development issues""}","{NULL,NULL,NULL}",,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PstMedHxNne,Past medical history - None,UDE,1,Subject has no past medical history,Subject has no past medical history,ALPHANUMERIC,,1,,,{none},{none},{NULL},,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PstMedHxPstSrgry,Past medical history - Past Surgery,UDE,1,Past medical history of the subject includes past surgeries,Past medical history of the subject includes past surgeries,ALPHANUMERIC,,2,,,"{Appendectomy,""Cardiac Surgery"",Cholecystectomy,C-Section,""Other Surgery""}","{appendectomy,""cardiac surgery"",cholecystectomy,c-section,other}","{NULL,NULL,NULL,NULL,NULL}",,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PstMedHxRsprtryDsse,Past medical history - Respiratory disease,UDE,1,Past medical history of the subject includes respriatory disease,Past medical history of the subject includes respiratory disease,ALPHANUMERIC,,2,,,"{""Asthma, on bronchodilator"",""Asthma NFS""}","{""asthma on bronchodilator"",""ashtma NSF""}","{NULL,NULL}",,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PstMedhxSclHx,Past medical history - Social history,UDE,1,Past medical history of the subject includes social history,Past medical history of the subject includes social history,ALPHANUMERIC,,2,,,"{""Alcohol dependence/Disorder"",""Do not Resuscitate (DNR)"",""Intravenous drug abuse-Disorder (NTDB)"",""Non-Intravenous drug abuse-Disorder"",""Tobacco use"",""Unspecified drug dependence-Disorder (NTDB)"",ADD/ADHD}","{""alcohol dependence/disorder"",""Do not resuscitate"",""intravenous drug abuse disorder"",""non=intravenous drug abuse disorder"",""tobacco use"",""unspecified drug dependence disorder"",ADD/ADHD}","{NULL,NULL,NULL,NULL,NULL,NULL,NULL}",,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PstMedHxThydDsse,Past medical history - Thyroid disease,UDE,1,Past medical history of the subject includes thyroid disease,Past medical history of the subject includes thyroid disease,ALPHANUMERIC,,2,,,{Hypothyroidism},{hypothyroidism},{NULL},,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PstMedHxVsclrDsse,Past medical history - Vascular disease,UDE,1,Past medical history of the subject includes vascular disease,Past medical history of the subject includes vascular disease,ALPHANUMERIC,,2,,,"{""Deep vein thrombosis"",Hypertension}","{""deep vein thrombosis"",hypertension}","{NULL,NULL}",,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
RaceUSACat,Race USA Category,CDE,1,Category of ethnicity the participant/subject most closely identifies with,Category of ethnicity the participant/subject most closely identifies with,ALPHANUMERIC,,2,,,"{""Not reported"",Asian,Unknown,""American Indian or Alaska Native"",""Black or African-American"",""Native Hawaiian or Other Pacific Islander"",White}","{""6=not provided or unavailable"",""2=A person having origins in any of the original peoples of the Far East, Southeast Asia, or the Indian subcontinent including, for example, Cambodia, China, India"",""999=could not be determined or unsure"",""1=A person having orginins in any of the original pepoles of North and South America (including Central America), and who maintains tribal affiliation or community attachment"",""3=a person having origins in any of the black racial groups of Africa"",""4=a person having origins in any of the original peoples of Hawaii, Guam, SAmoa, or other Pactific Islands"",""5=a person having origins in any of the original peoples of Europe, the Middle East, or North Africa""}","{6,2,999,1,3,4,5}",,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Rcrdvrfctndte,Record verification date,CDE,1,"The date on which the responsible party last verified the information in the entire expanded acces record, even if no additional orupdated information is being submitted","The date on which the responsible party last verified the information in the entire expanded acces record, even if no additional orupdated information is being submitted",DATE,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
RespRate,Respiratory Rate,CDE,1,Rate of the participant/subject's breathing (inhalation and exhalation).,Rate of the participant/subject's breathing (inhalation and exhalation).,NUMERIC,120,0,0,120,{NULL},{NULL},{NULL},Breaths per minute,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Rspnsblprty,Responsible party by official title,CDE,1,"An indication of whether the responsible party is the sponsor, the sponsor-investigator, or a principal investigator designated by the sponsor to be the responsible party.","An indication of whether the responsible party is the sponsor, the sponsor-investigator, or a principal investigator designated by the sponsor to be the responsible party.",ALPHANUMERIC,,1,,,"{Sponsor,Sponsor-Investigator,""Principal investigator""}","{""The entity (for example, corporation or agency) that initiates the study"",""The individual who both initiates and conducts the study"",""The individual designated as responsible party by the sponsor""}","{NULL,NULL,NULL}",,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
RTS,Revised Trauma Score,UDE,1,A physiogical scoring system for predicting death.,A physiological scoring system for predicting death,ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
RTSAdm05,RTS Adm 05,UDE,1,A physiogical scoring system for predicting death.,A physiological scoring system for predicting death,NUMERIC,8,0,0,8,{NULL},{NULL},{NULL},,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Sampmethd,Sampling method,CDE,1,"A description of the population from which the groups or cohorts will be selected (for example, primary care clinic, community sample, residents of a certain town).","A description of the population from which the groups or cohorts will be selected (for example, primary care clinic, community sample, residents of a certain town).",ALPHANUMERIC,,1,,,"{non-probability,probability}","{""any of a variety of other sampling proccess"",""exclusively rnadomprocess to guarantee that each participant has specified chance of selection""}","{NULL,NULL}",,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Scndryidnum,Secondary identification number,CDE,1,"An idenfitier(s), if any, other than the organization's unique protocol identification number or the NCT number that is assigned to the study","This includes any unique clinical stdy identifiers assigned by other clinical trial registries. If the clnical study is funded inwhiole or in part by a US Federal Government agency, the complete grant or contract nubmer must be submitted as a Secondary ID",ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Scndryidtyp,Secondary identification type,CDE,1,A description of the type of Secondary ID,A description of the type of Secondary ID,NUMERIC,,1,,,"{4,5,2,3,1}","{""4=EudraCT Number"",""5=Other Identifier"",""2=Other Grant/Funding Numer"",""3=Registry Identifier"",""1=US National Institute of Health (NIH) Grant/Contract Award Number""}","{NULL,NULL,NULL,NULL,NULL}",,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Scndryidtyp_othr,"Secondary identification type, other description",CDE,1,"If a Secondary ID Type of ""Other"" is given provide the name of the funding organization, clinical trial registr, or organization that issued the identfier","This includes any unique clinical stdy identifiers assigned by other clinical trial registries. If the clnical study is funded inwhiole or in part by a US Federal Government agency, the complete grant or contract nubmer must be submitted as a Secondary ID",ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,no references available,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Scndryotcmmeasr_dscrptn,Secondary outcome measure description,CDE,1,"Description of the metric used to characterize the specific secondary outcome measure, if not included in the secondary outcome measure title.","Description of the metric used to characterize the specific secondary outcome measure, if not included in the secondary outcome measure title.",ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Scndryotcmmeasr_tmfrm,Secondary outcome measure timeframe,CDE,1,Time point(s) at which the measurement is assessed for the specific metric used. The description of the time point(s) of assessment must be specific to the outcome measure and is generally the specific duration of time over which each participant is assessed (not the overall duration of the study).,Time point(s) at which the measurement is assessed for the specific metric used.,ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Scndryotcmmeasr_ttl,Secondary outcome measure title,CDE,1,Name of the specific secondary outcome measure,Name of the specific secondary outcome measure,ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SiteName,Site name,CDE,1,The name of the site for the study,The name of the site for the study,ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,Name of the site:,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SodiumLevel,Sodium Level,UDE,1,serum measurement of sodium,serum measurement of sodium,NUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Spine_AIS,Spine AIS,UDE,1,AIS severity of injury for this body region,AIS severity of injury for this body region,NUMERIC,,1,,,"{5,6,2,1,4,3}","{5,6,2,1,4,3}","{NULL,NULL,NULL,NULL,NULL,NULL}",,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Spnsrnme,Name of the sponsor,CDE,1,The name of the entity or the individual who is the sponsor of the clinical study.,The name of the entity or the individual who is the sponsor of the clinical study.,ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Stdyphse,Study phase,CDE,1,"For a clinical trial of a drug product (including a biological product), the numerical phase of such clinical trial, consistent with terminology in 21 CFR 312.21 and in 21 CFR 312.85 for phase 4 studies.","For a clinical trial of a drug product (including a biological product), the numerical phase of such clinical trial, consistent with terminology in 21 CFR 312.21 and in 21 CFR 312.85 for phase 4 studies.",ALPHANUMERIC,,1,,,"{4,6,3,5,2,7,1,8}","{""may include healthy participants and/or patients"",""Phase 2 Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks"",""Phase 1 Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness"",""Phase 1/Phase 2 Trials that are a combination of phases 1 and 2"",""Early Phase 1 Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent"",""Phase 2/Phase 3 Trials that are a combination of phases 2 and 3"",""N/A Trials without phases"",""Phase 3 Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug. Phase 4: Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.""}","{NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL}",,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Stdyppldscrptn,Study population description,CDE,1,"A description of the population from which the groups or cohorts will be selected (for example, primary care clinic, community sample, residents of a certain town).","A description of the population from which the groups or cohorts will be selected (for example, primary care clinic, community sample, residents of a certain town).",ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,"Alexander MS, Biering-Sorensen F, Elliott S, Kreuter M, Saanksen J. International Spinal Cord Injury Female Sexual and Reproductive Function Basic Data Set. Spinal Cord. 2011 Jul;49(7):787-90. Alexander MS, Biering-Sorensen F, Elliott S, Kreuter M, Saanksen J. International Spinal Cord Injury Male Sexual Function Basic Data Set. Spinal Cord. 2011 Jul;49(7):795-8. Bauman WA, Biering-Sorensen F, Krassioukov A. International spinal cord injury endocrine and metabolic function basic data set. Spinal Cord. 2011 Oct;49(10):1068-72. Biering-Sorensen F, Craggs M, Kennelly M, Schick E, Wyndaele JJ. International Lower Urinary Tract Function Basic Spinal Cord Injury Data Set. Spinal Cord 2008 May;46(5):325-30. Krogh K, Perkash I, Stiens SA, Biering-Sorensen F. International bowel function extended spinal cord injury data set. Spinal Cord. 2009 Mar;47(3):235-41. Widerstraam-Noga E, Biering-Sorensen F, Bryce T, Cardenas DD, Finnerup NB, Jensen MP, Richards JS, Siddall PJ. The international spinal cord injury pain basic data set. Spinal Cord. 2008 Dec;46(12):818-23.",Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Stdyttl,Study title,CDE,1,The title of the study,The title of the study,ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Stdytype,Study type,CDE,1,The nature of the investigation or investigational use for which clinical study information is being submitted,The nature of the investigation or investigational use for which clinical study information is being submitted,NUMERIC,,1,,,"{2,4,1,3,5,6}","{""2=Observational studies in human beings in which biomedical and/or health outcomes are assessed in pre-defined groups of individuals and may recieve diagnostic, therapeutic, or other interventions, but the investigator does not assign specific interventions to the study participants including when participants recieve interventions as part of routine medical care, and a researcher studies the effect of the intervetion"",""4=Expanded Assess investigational drug product (including biological product) available through expanded access for patients who do not qualify for enrollment in a cnilical trial"",""1=Interventional clinical trial whereby participants are assigned prospectively to an intervention or interventions according to a protocol to evaluate the effect of the intervention on biomedical or other health related otucomes"",""3=An investigational drug product (including biological product) available through expanded access for patients who do not qualify for enrollment in a clinical trial"",""5=Retrospecitve review"",""6=case study""}","{NULL,NULL,NULL,NULL,NULL,NULL}",,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Stte_prvnce,State/Province,CDE,1,State or Provence,State or Province,ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SubjectID,Subject identifier number,CDE,1,Unique identification number given to the study participant/subject,Unique identification number given to the study participant/subject.,ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,Subject ID number,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SysBloodPressr,Systolic Blood Pressure,CDE,1,Measurement of pressure of the participant's/subject's blood against the artery walls during systole (the contraction phase) in millimeters of mercury (mmHg),Measurement of pressure of the participant's/subject's blood against the artery walls during systole (the contraction phase) in millimeters of mercury (mmHg),NUMERIC,300,0,0,300,{NULL},{NULL},{NULL},Millimeters of Mercury,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Thorax_AIS,Thorax AIS,UDE,1,AIS severity of injury for this body region,AIS severity of injury for this body region,NUMERIC,,1,,,"{5,6,2,1,4,3}","{5,6,2,1,4,3}","{NULL,NULL,NULL,NULL,NULL,NULL}",,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Tmeprspctv,Time perspective,CDE,1,Temporal relationship of observation period to time ofparticpant enrollment.,Temporal relationship of observation period to time ofparticpant enrollment.,ALPHANUMERIC,,1,,,"{3,2,4,1}","{""Cross-sectional Observations or measurements made at a single point in time, usually at subject enrollment"",""Prospective Look forward using periodic observations collected predominantly following subject enrollment"",""Other Explain in Detailed Description"",""Retrospective Look back using observations collected predominantly prior to subject selection and enrollment""}","{NULL,NULL,NULL,NULL}",,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Tmeprspctv_othr,Time perspective - other,CDE,1,Time Perspective - Other Description,Time Perspective - Other Description,ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Transport_Origin,transport_origin,UDE,1,Location patient was transferred to facility from,Location patient was transferred to facility from,NUMERIC,,1,,,"{1,4,5,6,2,3}","{medivac,""public ambulance ALS"",""Commerical Helicopter"",""Private ambualnce unsepcified"",""public ambulance unspecified"",""other helicopter""}","{NULL,NULL,NULL,NULL,NULL,NULL}",,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TransportMode,transport mode,UDE,1,The mode of transport delivering the patient to your hospital,The mode of transport delivering the patient to your hospital,NUMERIC,,1,,,"{2,1}","{transfer,scene}","{NULL,NULL}",,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Trgtfllwup_drtnmeasr,Target follow-up duration measurement,CDE,1,"For Patient Registries, the anticipated time period over which each participant is to be followed.","For Patient Registries, the anticipated time period over which each participant is to be followed.",ALPHANUMERIC,,1,,,"{4,1,2,3}","{days,years,months,weeks}","{NULL,NULL,NULL,NULL}",,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Trgtfllwup_drtnnum,Target follow-up duration number,CDE,1,"For Patient Registries, the anticipated time period over which each participant is to be followed.","For Patient Registries, the anticipated time period over which each participant is to be followed.",NUMERIC,999999,0,0,999999,{NULL},{NULL},{NULL},,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TRISS,TRISS,UDE,1,A scoring mechanism for predicting patient probablity of survival,A scoring mechanims for predicting patient probablility of survival,ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Trnsprt_Mde,transport mode,UDE,1,The mode of transport delivering the patient to your hospital,The mode of transport delivering the patient to your hospital,ALPHANUMERIC,,1,,,"{""Public Ambulance Unspecified"",""Other Helicopter"",""Public ambulance-ALS"",""Commercial Helicopter"",""Private Ambulance Unspecified"",""Private ambulance-ALS""}","{"""","""","""","""","""",""""}","{NULL,NULL,NULL,NULL,NULL,NULL}",,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Trnsprt_Mode,transport mode,UDE,1,The mode of transport delivering the patient to your hospital,The mode of transport delivering the patient to your hospital,ALPHANUMERIC,,1,,,"{""Public Ambulance Unspecified"",""Other Helicopter"",Medivac,""Public ambulance-ALS"",""Private Ambulance Unspecified"",""Private ambulance-ALS"",""Commercial Hellicopter""}","{"""","""","""","""","""","""",""""}","{NULL,NULL,NULL,NULL,NULL,NULL,NULL}",,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TrnsprtMde,transport mode,UDE,1,The mode of transport delivering the patient to your hospital,The mode of transport delivering the patient to your hospital,ALPHANUMERIC,,1,,,"{""Public Ambulance Unspecified"",""Other Helicopter"",Medivac,""Public ambulance-ALS"",""Commercial Helicopter"",""Private Ambulance Unspecified"",""Private ambulance-ALS""}","{"""","""","""","""","""","""",""""}","{NULL,NULL,NULL,NULL,NULL,NULL,NULL}",,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
UE_AIS,Upper Extremity AIS,UDE,1,AIS severity of injury for this body region,AIS severity of injury for this body region,NUMERIC,,1,,,"{5,6,2,1,4,3}","{5,6,2,1,4,3}","{NULL,NULL,NULL,NULL,NULL,NULL}",,,,,,21 CFR 50.20 General requirements for informed consent A Guide to Informed Consent - Information Sheet: Guidance for Institutional Review Boards and Clinical Investigators Contents (http://www.fda.gov/RegulatoryInformation/Guidances/ucm126431.htm#general,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Unique_ID,Unique Identifier,CDE,1,A Unique Identifier created by the NTRR system (Pseudo GUID or GUID),A Unique Identifier created by the NTRR system (Pseudo GUID or GUID),GUID,,0,,,{NULL},{NULL},{NULL},,,,What is the Unique Identifier created by the NTRR system f(Pseudo GUID or GUID) or this subject?,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Unique_Identifier,Unique Identifier,CDE,1,A Unique Identifier created by the NTRR system (Pseudo GUID or GUID),A Unique Identifier created by the NTRR system (Pseudo GUID or GUID),ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,What is the Unique Identifier created by the NTRR system f(Pseudo GUID or GUID) or this subject?,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Vent_days,Ventilator Days,UDE,1,"Total length of mechanical ventilation (days, both invasive and noninvasive)","Total length of mechanical ventilation (days, both invasive and noninvasive)",ALPHANUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult and Pediatric,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VisitDate,Visit Date,CDE,1,Interview or visit date (actually the date when data in the form were captured),Interview or visit date,DATE,,0,,,{NULL},{NULL},{NULL},,,,Vist date:,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VitalSgnDateTime,Vital signs date and time,UDE,1,"Date (and time, if applicable and known) the vital signs and other body measurements were taken by indicating the month, day, and year for the date and am, pm, or 24 hour clock for time","Date (and time, if applicable and known) the vital signs and other body measurements were taken by indicating the month, day, and year for the date and am, pm, or 24 hour clock for time",DATE,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WBC,WBC,UDE,1,Total white blood cell count value,Total white blood cell count value,NUMERIC,,0,,,{NULL},{NULL},{NULL},,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WgtMeasr,Weight Measurement,CDE,1,Measurement of participant's/subject's weight,Measurement of participant's/subject's weight,NUMERIC,500,0,0,500,{NULL},{NULL},{NULL},Kilogram,,,,,,Adult,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
